Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3046% above fair value
$29.45+0.09 (+0.31%)
Close on Nov 11, 2026Market cap $167.86BP/E 42.1Yield 5.84%
Pfizer enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pfizer's enterprise value was $223.08B on Nov 10, 2026, against $197.42B a year earlier. Over the last 5 years it ranged from $179.81B to $345.90B, with a median of $223.08B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $223.08B | +15.8% |
| 2025 | Dec 31, 2025 | $192.63B | -8.8% |
| 2024 | Dec 31, 2024 | $211.14B | +6.3% |
| 2023 | Dec 29, 2023 | $198.71B | -35.8% |
| 2022 | Dec 30, 2022 | $309.48B | -10.5% |
| 2021 | Dec 31, 2021 | $345.90B | +39.2% |
| 2020 | Dec 31, 2020 | $248.44B | -7.6% |
| 2019 | Dec 31, 2019 | $268.94B | -6.1% |
| 2018 | Dec 31, 2018 | $286.56B | +15.9% |
| 2017 | Dec 29, 2017 | $247.15B | +6.9% |
| 2016 | Dec 30, 2016 | $231.17B | +4.4% |
| 2015 | Dec 31, 2015 | $221.49B | +7.9% |
| 2014 | Dec 31, 2014 | $205.27B | -7.1% |
| 2013 | Dec 31, 2013 | $220.91B | +6.9% |
| 2012 | Dec 31, 2012 | $206.58B | +11.8% |
| 2011 | Dec 30, 2011 | $184.80B | +13.5% |
| 2010 | Dec 31, 2010 | $162.81B | +48.2% |
| 2009 | Dec 31, 2009 | $109.84B | – |
See a number that looks wrong?